Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
amgen
biohaven
2
×
biotech
2
×
clinical trials
eli lilly
fda
life sciences
migraine
national
national blog main
national top stories
new york blog main
abbvie
alder biopharmaceutical
american academy of neurology
atogepant
bob azelby
boston blog main
boston top stories
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
cgpr
detroit blog main
detroit top stories
drugs
eptinezumab
erenumab
europe blog main
fremanezumab
galcanezumab
impel neuropharma
indiana blog main
indiana top stories
jefferies
lasmiditan
marc goodman
What
class
2
×
fda
2
×
migraine
new
adults
allergan
approval
approved
arguments
big
commercialized
companies
competitors
decades
drug
drugs
make
medicines
meeting
monday
neuro
nod
oral
pill
potential
therapies
treat
treatment
ubrelvy
ubrogepant
wins
won
year
Language
unset
Current search:
biohaven
×
biotech
×
class
×
fda
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments